Literature DB >> 33091446

Digging deeper through glucose metabolism and its regulators in cancer and metastasis.

Majid Ghanavat1, Mehdi Shahrouzian2, Zeinab Deris Zayeri3, Sara Banihashemi4, Seyedeh Maryam Kazemi5, Najmaldin Saki6.   

Abstract

Glucose metabolism enzymes and transporters play major role in cancer development and metastasis. In this study, we discuss glucose metabolism, transporters, receptors, hormones, oncogenes and tumor suppressors which interact with glucose metabolism and we try to discuss their major role in cancer development and cancer metabolism. We try to highlight the. Metabolic changes in cancer and metastasis upregulation of glycolysis is observed in many primary and metastatic cancers and aerobic glycolysis is the most favorable mechanism for glucose metabolism in cancer cells, and it is a kind of evolutionary change. The question that is posed at this juncture is: Can we use aerobic glycolysis phenotype and enzymes beyond this mechanism in estimating cancer prognosis and metastasis? Lactate is a metabolite of glucose metabolism and it is a key player in cancer and metastasis in both normoxic and hypoxic condition so lactate dehydrogenase can be a good prognostic biomarker. Furthermore, monocarboxylic transporter which is the main lactate transporter can be good target in therapeutic studies. Glycolysis enzymes are valuable enzymes in cancer and metastasis diagnosis and can be used as therapeutic targets in cancer treatment. Designing a diagnostic and prognostic profile for cancer metastasis seems to be possible base on glycolysis enzymes and glucose transporters. Also, glucose metabolism enzymes and agents can give us a clear vision in estimating cancer metastasis. We can promote a panel of genes that detect genetic changes in glucose metabolism agents to diagnose cancer metastasis.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Cancer; Glucose; Glycolysis; Hormone; Metabolism; Oncogene; Tumor suppressor

Mesh:

Substances:

Year:  2020        PMID: 33091446     DOI: 10.1016/j.lfs.2020.118603

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

Review 1.  The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.

Authors:  Jinyan Wang; Lijuan Chen; Ping Qiang
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

2.  Nanostructured Layer of Silver for Detection of Small Biomolecules in Surface-Assisted Laser Desorption Ionization Mass Spectrometry.

Authors:  Adrian Arendowski; Gulyaim Sagandykova; Radik Mametov; Katarzyna Rafińska; Oleksandra Pryshchepa; Paweł Pomastowski
Journal:  Materials (Basel)       Date:  2022-06-08       Impact factor: 3.748

3.  Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis.

Authors:  Siyi Ni; Yingchao Liu; Jihong Zhong; Yan Shen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.

Authors:  Kunpeng Du; Jingwen Zou; Baiyao Wang; Chunshan Liu; Muhammad Khan; Tao Xie; Xiaoting Huang; Piao Shen; Yunhong Tian; Yawei Yuan
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 5.  Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation.

Authors:  Chelsea Schiliro; Bonnie L Firestein
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

Review 6.  Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma.

Authors:  Taiana Campos Leite; Rebecca Jean Watters; Kurt Richard Weiss; Giuseppe Intini
Journal:  J Transl Med       Date:  2021-10-29       Impact factor: 5.531

Review 7.  miR-199a: A Tumor Suppressor with Noncoding RNA Network and Therapeutic Candidate in Lung Cancer.

Authors:  Wei Meng; Yanli Li; Binshu Chai; Xiaomin Liu; Zhongliang Ma
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

Review 8.  Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies.

Authors:  Ioana-Ecaterina Pralea; Alina-Maria Petrache; Adrian Bogdan Tigu; Diana Gulei; Radu-Cristian Moldovan; Maria Ilieș; Raul Nicoară; Simona-Codruța Hegheș; Alina Uifălean; Cristina-Adela Iuga
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-28

9.  New perspective of ceria nanodots for precise tumor therapy via oxidative stress pathway.

Authors:  Hui Wang; Qi Wang; Jianyue Dong; Weiwei Jiang; Linghong Kong; Qiong Zhang; Hanping Liu
Journal:  Heliyon       Date:  2022-08-23

10.  Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients.

Authors:  Jiayue Zou; Yanlin Gu; Qi Zhu; Xiaohua Li; Lei Qin
Journal:  Cancer Biomark       Date:  2022       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.